Lincoln Pharmaceuticals fundamental analysis
LINCOLN
485
4.70 (-0.96%)Last updated on 24 Dec, 2025 | 15:29 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Lincoln Pharmaceuticals Fundamentals
P/E Ratio
12.28
P/B Ratio
1.37
Div. Yield
0.37
Sector P/E
71.29
Sector P/B
1.09
Sec. Div. Yield
0.56
Lincoln Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 12.28, compared to the sector average of 71.29. Its P/B Ratio stands at 1.37, while the sector’s is 1.09. In terms of returns, the stock offers a Dividend Yield of 0.37%, which is than the sector’s 0.56%.
Lincoln Pharmaceuticals Score Card
Price
Expensive
Growth
Average
Quality
Good
Management
Good
On its scorecard, Lincoln Pharmaceuticals reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
